Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

NCT02453711 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02453711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02453711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
October 1, 2015
Completion date
April 12, 2017
Enrollment
957 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

metabolism and nutrition disorder, obesity